Original language | Undefined/Unknown |
---|---|
Pages (from-to) | 216-228 |
Number of pages | 13 |
Journal | Lancet Oncology |
Volume | 20 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2019 |
Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study
Jacoline Bromberg, S Issa, Katerina Bakunina, MC Minnema, T Seute, M Durian, G Cull, HC Schouten, WBC Stevens, JM Zijlstra, JW Baars, M Nijland, KD Mason, A Beeker, Martin van den Bent, M Beijert, M Gonzales, D Jong, Jeanette Doorduijn
Research output: Contribution to journal › Article › Academic › peer-review
113
Citations
(Scopus)